Flupenthixol Decanoate in Methamphetamine Smoking - 1
Completed · Phase 2
Conditions studied: Substance-Related Disorders
In brief
The purpose of this study is to evaluate the safety and efficacy of flupenthixol decanoate for treatment of methamphetamine dependence. Also, study will compare flupenthixol with desipramine in blocking methamphetamine self-administration.
Key facts
- Study ID
- NCT00000241
- Run by
- National Institute on Drug Abuse (NIDA)
- People needed
- 58
- Starts
- 1994-02-01
- Expected to finish
- 1996-05-01
- Last updated by the study team
- 2017-01-12
Who can join
Age: 22 and older, up to 45. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Friends Research Institute — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.